NCT04383210 2025-04-03Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid TumorsElevation OncologyPhase 2 Terminated54 enrolled 11 charts
NCT02164461 2024-05-20Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical CancerAdvaxis, Inc.Phase 1 Completed12 enrolled 18 charts
NCT04424641 2023-07-25A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid TumorsGenmabPhase 1/2 Terminated48 enrolled 20 charts
NCT03989115 2023-06-26Dose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLCRevolution Medicines, Inc.Phase 1/2 Completed113 enrolled 22 charts
NCT03073525 2023-04-05A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological CancersGradalis, Inc.Phase 2 Completed25 enrolled 15 charts
NCT01420081 2019-01-08A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial CancerPfizerPhase 2 Terminated67 enrolled 37 charts
NCT01379534 2015-05-20A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial CancerNovartisPhase 2 Completed53 enrolled 10 charts
NCT01045187 2012-08-01Feasibility Study Using the Xoft System for the Treatment of Endometrial CancerXoft, Inc.Phase NA Completed15 enrolled 5 charts
NCT00628901 2012-07-11A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE)Boston Scientific CorporationPhase 4 Completed60 enrolled 39 charts
NCT00377520 2009-11-20A Trial for Patients With Advanced/Recurrent Endometrial CancerEli Lilly and CompanyPhase 2 Completed27 enrolled 10 charts